Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States
Evan J. Anderson(Emory University), Christina A. Rostad(Emory University), Caroline Ciric(Emory University), Kieffer Hellmeister(Emory University), Sonal Uppal(Pfizer (United States)), Meg Taylor(Emory University), Nadine Rouphael(Emory University), Ashley Tippett(Emory University), Theda Gibson(Emory University), Laurel Bristow(Emory University), Olivia Reese(Emory University), Bradford D. Gessner(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Luis Jódar(Pfizer (United States)), Andrew Cheng(Emory University), Elizabeth Begier(Pfizer (United States)), Luis W Salazar(Emory University), David L. Swerdlow(Pfizer (United States)), Kathleen Stephens(Emory University), Vikash Patel(Emory University), Zayna Al-Husein(Emory University), Gabby Ess(Emory University), Qing Liu(Hong Kong Polytechnic University), Wensheng Li(Emory University), Amy Keane(Emory University), Larry J. Anderson(United States Department of Health and Human Services), Hui‐Mien Hsiao(Emory University), He-Ying Sun(Emory University), Shadwal Gupta(Emory University), Samadhan Jadhao(Centers for Disease Control and Prevention), Robin Hubler(Pfizer (United States)), Satoshi Kamidani(Emory University)
Cited by 12
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k